These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3468901)

  • 1. The questionable value of long-term animal toxicity studies: a regulatory dilemma.
    Lumley CE; Walker SR
    Arch Toxicol Suppl; 1986; 9():237-9. PubMed ID: 3468901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of chronic animal toxicology studies of pharmaceutical compounds: A retrospective analysis.
    Lumley CE; Walker SR
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1007-24. PubMed ID: 4092866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international appraisal of the minimum duration of chronic animal toxicity studies.
    Lumley CE; Parkinson C; Walker SR
    Hum Exp Toxicol; 1992 May; 11(3):155-62. PubMed ID: 1352109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical appraisal of the duration of chronic animal toxicity studies.
    Lumley CE; Walker SR
    Regul Toxicol Pharmacol; 1986 Mar; 6(1):66-72. PubMed ID: 3704209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A toxicology databank based on animal safety evaluation studies of pharmaceutical compounds.
    Lumley CE; Walker SR
    Hum Toxicol; 1985 Jul; 4(4):447-59. PubMed ID: 4018825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative retrospective analysis of data from short- and long-term animal toxicity studies on 40 pharmaceutical compounds.
    Walker SR; Schuetz E; Schuppan D; Gelzer J
    Arch Toxicol Suppl; 1984; 7():485-7. PubMed ID: 6596020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of 2-year carcinogenicity study results for pharmaceutical products: how are we doing?
    Jacobs A
    Toxicol Sci; 2005 Nov; 88(1):18-23. PubMed ID: 16002477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmonization of guidelines for toxicity testing of pharmaceuticals by 1992.
    Speid LH; Lumley CE; Walker SR
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):179-211. PubMed ID: 2259757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of information generated by long-term toxicity studies in the dog for the nonclinical safety assessment of pharmaceutical compounds.
    Parkinson C; Lumley CE; Walker SR
    Fundam Appl Toxicol; 1995 Apr; 25(1):115-23. PubMed ID: 7601320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development.
    Barrow PC; Schmitt G
    Methods Mol Biol; 2017; 1641():25-67. PubMed ID: 28748457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009).
    Friedrich A; Olejniczak K
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):225-48. PubMed ID: 21513764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic characteristics of fourteen main components of Gegen Qinlian Decoction in rats].
    Yi Y; Zhao Y; Li CY; Zhang YS; Pan C; Liu SY; Jiang CH; Liang AH
    Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(23):4735-4740. PubMed ID: 30717565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models: their use and limitations in long-term safety evaluation of fertility-regulating agents.
    Heywood R
    Hum Reprod; 1986 Sep; 1(6):397-9. PubMed ID: 3558786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
    Berghmans S; Butler P; Goldsmith P; Waldron G; Gardner I; Golder Z; Richards FM; Kimber G; Roach A; Alderton W; Fleming A
    J Pharmacol Toxicol Methods; 2008; 58(1):59-68. PubMed ID: 18585469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.